DrugDashboards

Tom Ford Architecture Radiance Hydrating Foundation Broad Spectrum Spf 50

ensulizole, octinoxate, octisalate, and zinc oxide · OCTINOXATE 65 mg/mL; OCTISALATE 30 mg/mL; ZINC OXIDE 53 mg/mL; ENSULIZOLE 27 mg/mL · Emulsion · Topical · Tom Ford Beauty Dist

NDC 76398-0015-01 · 1 BOTTLE, PUMP in 1 CARTON / 30 mL in 1 BOTTLE, PUMP · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
M020
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of ensulizole, octinoxate, octisalate, and zinc oxide (Emulsion)

LabelerStrengthFirst seenLast seen
Tom Ford Beauty DistOCTINOXATE 65 mg/mL; OCTISALATE 30 mg/mL; ZINC OXIDE 53 mg/mL; ENSULIZOLE 27 mg/mLAug 26, 2026Sep 2, 2026
Tom Ford Beauty DistOCTINOXATE 27 mg/mL; OCTISALATE 65 mg/mL; ZINC OXIDE 30 mg/mL; ENSULIZOLE 53 mg/mLJul 22, 2026Aug 19, 2026
Tom Ford Beauty DistENSULIZOLE 27 mg/mL; OCTINOXATE 65 mg/mL; OCTISALATE 30 mg/mL; ZINC OXIDE 53 mg/mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Tom Ford Architecture Radiance Hydrating Foundation Broad Spectrum Spf 50 — NDC 76398-0015-01," retrieved September 3, 2026, https://drugdashboards.com/drug/76398001501.

Free to cite with attribution — see how the data is put together.